Exciting news! ๐ Don't miss our upcoming Cancer Neuroscience podcast episode featuring keynote speaker Dr. Erica Sloan. She dives into the fascinating topic of the mind-tumor connection and its impact on treatment responses, offering insightful perspectives.
https://t.co/fNFBjPSFv3
Mark your calendars for February 2026 to engage with Dr. Sloan in person at the MD Anderson-Wiley Cancer Neuroscience symposia in Houston, Texas. It's a unique opportunity to delve deeper into this crucial field.
Ready to participate? Registration is now open!
Registration is open for the International Cancer Neuroscience Symposium! Join 30+ experts, including Nobel Laureate Dr. James P. Allison, to shape the future of this emerging field.
๐ Houston or online
๐ Register: https://t.co/ZoKNDgKJns
#CancerNeuroscience#AdvancedPortfolio
@WomenScienceDay thank you the amazing class of 2025 @CSHL methods in cancer neuroscience. All #women (but Jeremy, not in the image ๐). What a great era to live in.
@CanNeuroSociety
#EndCancer@MDAndersonNews
Today it starts! Happy to be part of this legacy. The first new course CSHL opening in a while, and itโs Methods in Cancer Neuroscience.
Itโs a beautiful morning, time to ring the bell!
Making (cancer) history, one neuron at a time!
@MDAndersonNews@CSHL#CancerNeuroscience #EndCancer
The history of science is part of every path, corner and building of this place, makes me feel so humble. Thank you Jeremy, Pay, Ece, Olivia and our amazing class #1. For many more to come!
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as โindirect costs.โ Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
Dr. Mariana Chavez-MacGregor shares insights on a recent report that says women under 50 have an 82% higher cancer incidence rate than their male counterparts: https://t.co/c2jnKcbtzS #EndCancer
@joerogan Yes! for the first time #psilocybin is available for #Cancer patients undergoing treatment facing #depression or #anxiety. Full psilocybin assisted therapy package. @MD Anderson cancer center. if you know someone who is struggling please email us at [email protected]
@RobertKennedyJr Letโs make it a great year for cancer patients by making #Psilocybin accessible to them! After 4 years of extensive work with the authorities Iโm so pleased to announce that we just opened the first #Psilocybin study for #Cancer patients struggling with #anxiety #depression and #PTSD undergoing treatment. Open for all.
[email protected]
@elonmusk@elonmusk me too! Letโs make it a great year for cancer patients struggling with anxiety and depression by making #Psilocybin accessible to them. We just opened the TRIP trial, if you know someone who is struggling, just let us know. open for all. In Texas and the nation.
@elonmusk@elonmusk me too! Letโs make it a great year for cancer patients struggling with anxiety and depression by making #Psilocybin accessible to them. We just opened the TRIP trial, if you know someone who is struggling, just let us know. open for all. In Texas and the nation.